P

Portage Biotech
D

PRTG

4.61000
USD
-0.01
(-0.22%)
Market Closed
Volume
55
EPS
-3
Div Yield
-
P/E
0
Market Cap
4,834,807
News

Title: Portage Biotech Inc

Sector: Healthcare
Industry: Biotechnology
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immuneresistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.